International Stem Cell Corporation
ISCO
$0.51
$0.024.49%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 7.42% | -9.03% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.42% | -9.03% | |||
| Cost of Revenue | -10.51% | 1.72% | |||
| Gross Profit | 24.98% | -17.56% | |||
| SG&A Expenses | -23.18% | 69.88% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.50% | 8.48% | |||
| Operating Income | 39.30% | -432.98% | |||
| Income Before Tax | 36.78% | -710.53% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 36.78% | -710.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 36.78% | -710.53% | |||
| EBIT | 39.30% | -432.98% | |||
| EBITDA | 39.77% | -272.67% | |||
| EPS Basic | 36.78% | -1,308.33% | |||
| Normalized Basic EPS | 36.76% | -704.44% | |||
| EPS Diluted | 36.78% | -1,308.33% | |||
| Normalized Diluted EPS | 36.76% | -718.18% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | -1.99% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||